Cargando…
Safety Studies for Use of Adipose Tissue‐Derived Mesenchymal Stromal/Stem Cells in a Rabbit Model for Osteoarthritis to Support a Phase I Clinical Trial
Adipose‐derived mesenchymal stem cells (AMSCs) offer potential as a therapeutic option for clinical applications in musculoskeletal regenerative medicine because of their immunomodulatory functions and capacity for trilineage differentiation. In preparation for a phase I clinical trial using AMSCs t...
Autores principales: | Riester, Scott M., Denbeigh, Janet M., Lin, Yang, Jones, Dakota L., de Mooij, Tristan, Lewallen, Eric A., Nie, Hai, Paradise, Christopher R., Radel, Darcie J., Dudakovic, Amel, Camilleri, Emily T., Larson, Dirk R., Qu, Wenchun, Krych, Aaron J., Frick, Matthew A., Im, Hee‐Jeong, Dietz, Allan B., Smith, Jay, van Wijnen, Andre J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442773/ https://www.ncbi.nlm.nih.gov/pubmed/28297568 http://dx.doi.org/10.5966/sctm.2016-0097 |
Ejemplares similares
-
Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production
por: Camilleri, Emily T., et al.
Publicado: (2016) -
Osteogenic Stimulation of Human Adipose‐Derived Mesenchymal Stem Cells Using a Fungal Metabolite That Suppresses the Polycomb Group Protein EZH2
por: Samsonraj, Rebekah M., et al.
Publicado: (2017) -
RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren’s disease
por: Riester, Scott M., et al.
Publicado: (2015) -
Erratum to: RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren’s disease
por: Riester, Scott M., et al.
Publicado: (2016) -
MicroRNA-101a enhances trabecular bone accrual in male mice
por: Dudakovic, Amel, et al.
Publicado: (2022)